SCHEMBL3389008

SCHEMBL3389008

CCCn1cc(I)c2ccncc21

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 10/20 0.46
NFATC1 O95644 6/20 0.46
GSK3B P49841 6/20 0.46
HASPIN Q8TF76 1/20 0.43
CNR2 P34972 3/20 0.42
CNR1 P21554 2/20 0.42
KCNH2 Q12809 3/20 0.41
KDM4C Q9H3R0 2/20 0.38
KDM5A P29375 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
CDK2 P24941 1/20 0.34
DYRK1B Q9Y463 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21917173 0.87 DYRK1A (0.43) DYRK1ANFATC1GSK3BHASPINCNR2
SCHEMBL21917362 0.84 DYRK1A (0.46) DYRK1ANFATC1GSK3BHASPINCNR2
SCHEMBL253653 0.83 DYRK1A (0.67) DYRK1ANFATC1GSK3BHASPINCNR2
SCHEMBL21917360 0.81 DYRK1A (0.44) DYRK1ANFATC1GSK3BHASPINCNR2
SCHEMBL4858180 0.81 DYRK1A (0.46) DYRK1ANFATC1GSK3BCNR2CNR1
SCHEMBL21917170 0.79 TBXAS1 (0.46) DYRK1ANFATC1GSK3BCNR2CNR1
SCHEMBL4851744 0.79 DYRK1A (0.49) DYRK1ANFATC1GSK3BHASPINCNR2
SCHEMBL15388885 0.78 HASPIN (0.61) DYRK1ANFATC1GSK3BHASPINKCNH2
SCHEMBL4857118 0.77 DYRK1A (0.57) DYRK1ANFATC1GSK3BHASPINCNR2
SCHEMBL14203016 0.76 CNR2 (0.57) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012000595-A1 2,4- DIARYL - SUBSTITUTED [1,8] NAPHTHYRIDINES AS KINASE INHIBITORS FOR USE AGAINST CANCER MERCK PATENT GMBH (DE) 2012-01-05 WO disclosed